Cargando…

The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017

BACKGROUND: Abuse of prescription opioids [opioid use disorder (OUD), poisoning, and fatal and non-fatal overdose] is a public health and economic challenge that is associated with considerable morbidity and mortality in the USA and globally. OBJECTIVE: To systematically review and summarize the hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinhart, Marcia, Scarpati, Lauren M., Kirson, Noam Y., Patton, Cody, Shak, Nina, Erensen, Jennifer G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132448/
https://www.ncbi.nlm.nih.gov/pubmed/30027533
http://dx.doi.org/10.1007/s40258-018-0402-x
_version_ 1783354324473085952
author Reinhart, Marcia
Scarpati, Lauren M.
Kirson, Noam Y.
Patton, Cody
Shak, Nina
Erensen, Jennifer G.
author_facet Reinhart, Marcia
Scarpati, Lauren M.
Kirson, Noam Y.
Patton, Cody
Shak, Nina
Erensen, Jennifer G.
author_sort Reinhart, Marcia
collection PubMed
description BACKGROUND: Abuse of prescription opioids [opioid use disorder (OUD), poisoning, and fatal and non-fatal overdose] is a public health and economic challenge that is associated with considerable morbidity and mortality in the USA and globally. OBJECTIVE: To systematically review and summarize the health economics literature published over the last 5 years that describes the economic burden of abuse of prescription opioids. METHODS: Findings from searches of databases including MEDLINE, Embase, and Cochrane CENTRAL as well as hand searches of multiple conference abstracts were screened against predefined inclusion criteria to identify studies reporting cost and healthcare resource utilization (HRU) data associated with abuse of prescription opioids. RESULTS: A total of 49 unique studies were identified. Most of the studies examined direct costs and HRU, which were substantially higher for abusers of prescription opioids than non-abuser controls in several matched cohort analyses (US$20,343–US$28,718 vs US$9716–US$14,079 for mean direct combined annual healthcare costs reported in 6 studies). Although only a small number of studies reported indirect costs, these findings suggest a high societal burden related to productivity losses, absenteeism, morbidity, and mortality among those who abuse opioids. Studies of medication-assisted treatment demonstrated that factors such as adherence, dose, formulation (film or tablet), and relapse during treatment, were associated with direct costs and HRU among treated patients. CONCLUSIONS: This systematic literature review shows that abuse of prescription opioids is characterized by substantial direct healthcare costs, medical utilization, and related societal costs. Future research should further investigate the indirect costs of opioid abuse. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-018-0402-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6132448
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-61324482018-09-14 The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017 Reinhart, Marcia Scarpati, Lauren M. Kirson, Noam Y. Patton, Cody Shak, Nina Erensen, Jennifer G. Appl Health Econ Health Policy Systematic Review BACKGROUND: Abuse of prescription opioids [opioid use disorder (OUD), poisoning, and fatal and non-fatal overdose] is a public health and economic challenge that is associated with considerable morbidity and mortality in the USA and globally. OBJECTIVE: To systematically review and summarize the health economics literature published over the last 5 years that describes the economic burden of abuse of prescription opioids. METHODS: Findings from searches of databases including MEDLINE, Embase, and Cochrane CENTRAL as well as hand searches of multiple conference abstracts were screened against predefined inclusion criteria to identify studies reporting cost and healthcare resource utilization (HRU) data associated with abuse of prescription opioids. RESULTS: A total of 49 unique studies were identified. Most of the studies examined direct costs and HRU, which were substantially higher for abusers of prescription opioids than non-abuser controls in several matched cohort analyses (US$20,343–US$28,718 vs US$9716–US$14,079 for mean direct combined annual healthcare costs reported in 6 studies). Although only a small number of studies reported indirect costs, these findings suggest a high societal burden related to productivity losses, absenteeism, morbidity, and mortality among those who abuse opioids. Studies of medication-assisted treatment demonstrated that factors such as adherence, dose, formulation (film or tablet), and relapse during treatment, were associated with direct costs and HRU among treated patients. CONCLUSIONS: This systematic literature review shows that abuse of prescription opioids is characterized by substantial direct healthcare costs, medical utilization, and related societal costs. Future research should further investigate the indirect costs of opioid abuse. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s40258-018-0402-x) contains supplementary material, which is available to authorized users. Springer International Publishing 2018-07-20 2018 /pmc/articles/PMC6132448/ /pubmed/30027533 http://dx.doi.org/10.1007/s40258-018-0402-x Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Systematic Review
Reinhart, Marcia
Scarpati, Lauren M.
Kirson, Noam Y.
Patton, Cody
Shak, Nina
Erensen, Jennifer G.
The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
title The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
title_full The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
title_fullStr The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
title_full_unstemmed The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
title_short The Economic Burden of Abuse of Prescription Opioids: A Systematic Literature Review from 2012 to 2017
title_sort economic burden of abuse of prescription opioids: a systematic literature review from 2012 to 2017
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132448/
https://www.ncbi.nlm.nih.gov/pubmed/30027533
http://dx.doi.org/10.1007/s40258-018-0402-x
work_keys_str_mv AT reinhartmarcia theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT scarpatilaurenm theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT kirsonnoamy theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT pattoncody theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT shaknina theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT erensenjenniferg theeconomicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT reinhartmarcia economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT scarpatilaurenm economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT kirsonnoamy economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT pattoncody economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT shaknina economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017
AT erensenjenniferg economicburdenofabuseofprescriptionopioidsasystematicliteraturereviewfrom2012to2017